Guicheney P, Devynck M A, Cloix J F, Pernollet M G, Grichois M L, Meyer P
Département de Pharmacologie, INSERM U6, Hôpital Necker, Paris, France.
J Hypertens. 1988 Nov;6(11):873-9. doi: 10.1097/00004872-198811000-00005.
A decrease in platelet 5-HT content linked to partial inhibition of 5-HT uptake has been described in essential hypertension. Transport of 5-HT through platelet membrane is dependent upon transmembranal Na+ and K+ gradients. It is inhibited by Na+, K+-ATPase inhibitors such as ouabain and endogenous digitalis-like compounds isolated from hemodiafiltrate. The activity of such compounds in plasma extracts, measured by inhibition of Na+,K+-ATPase or ouabain binding to human erythrocytes, and platelet 5-HT content were determined in parallel in essential hypertensive patients. Significant negative correlations were observed between these parameters in men, suggesting that high levels of digitalis-like compounds can affect platelet 5-HT content. In addition, in essential hypertensive patients, total plasma cholesterol was inversely related to both platelet 5-HT content (n = 15, r = -0.594, P less than 0.02) and maximal velocity of 5-HT uptake (n = 15, r = -0.717, P less than 0.003). In normotensive control subjects, no variation of platelet 5-HT content with cholesterol was observed. This suggests that the platelet membranes of essential hypertensive patients are more sensitive to increases in plasma cholesterol than those of normotensive subjects.
在原发性高血压中,已发现血小板5-羟色胺(5-HT)含量的降低与5-HT摄取的部分抑制有关。5-HT通过血小板膜的转运依赖于跨膜的Na+和K+梯度。它受到哇巴因等Na+,K+-ATP酶抑制剂以及从血液透析滤过液中分离出的内源性洋地黄样化合物的抑制。通过抑制Na+,K+-ATP酶或哇巴因与人红细胞的结合来测定血浆提取物中此类化合物的活性,并同时测定原发性高血压患者的血小板5-HT含量。在男性中,这些参数之间观察到显著的负相关,表明高水平的洋地黄样化合物可影响血小板5-HT含量。此外,在原发性高血压患者中,总血浆胆固醇与血小板5-HT含量(n = 15,r = -0.594,P <0.02)和5-HT摄取的最大速度(n = 15,r = -0.717,P <0.003)均呈负相关。在血压正常的对照受试者中,未观察到血小板5-HT含量随胆固醇的变化。这表明原发性高血压患者的血小板膜比血压正常的受试者对血浆胆固醇升高更敏感。